1. Home
  2. TALO vs EVO Comparison

TALO vs EVO Comparison

Compare TALO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TALO
  • EVO
  • Stock Information
  • Founded
  • TALO 2011
  • EVO 1993
  • Country
  • TALO United States
  • EVO Germany
  • Employees
  • TALO N/A
  • EVO N/A
  • Industry
  • TALO Oil & Gas Production
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TALO Energy
  • EVO Health Care
  • Exchange
  • TALO Nasdaq
  • EVO Nasdaq
  • Market Cap
  • TALO 1.5B
  • EVO 1.4B
  • IPO Year
  • TALO N/A
  • EVO 2021
  • Fundamental
  • Price
  • TALO $9.36
  • EVO $3.76
  • Analyst Decision
  • TALO Buy
  • EVO Buy
  • Analyst Count
  • TALO 8
  • EVO 2
  • Target Price
  • TALO $14.25
  • EVO $5.90
  • AVG Volume (30 Days)
  • TALO 3.0M
  • EVO 159.9K
  • Earning Date
  • TALO 08-06-2025
  • EVO 08-13-2025
  • Dividend Yield
  • TALO N/A
  • EVO N/A
  • EPS Growth
  • TALO N/A
  • EVO N/A
  • EPS
  • TALO 0.14
  • EVO N/A
  • Revenue
  • TALO $2,055,748,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • TALO N/A
  • EVO $10.08
  • Revenue Next Year
  • TALO N/A
  • EVO $10.99
  • P/E Ratio
  • TALO $64.45
  • EVO N/A
  • Revenue Growth
  • TALO 31.54
  • EVO 1.50
  • 52 Week Low
  • TALO $6.23
  • EVO $2.84
  • 52 Week High
  • TALO $12.71
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • TALO 66.13
  • EVO 41.37
  • Support Level
  • TALO $9.13
  • EVO $4.06
  • Resistance Level
  • TALO $9.72
  • EVO $4.44
  • Average True Range (ATR)
  • TALO 0.37
  • EVO 0.11
  • MACD
  • TALO 0.10
  • EVO -0.04
  • Stochastic Oscillator
  • TALO 81.66
  • EVO 0.00

About TALO Talos Energy Inc.

Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: